Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
Don't worry.
We will email you instructions to reset your
password.
Carrothers, S, Lockee, B, Williams, D, DeWit, E, McDonough, R, Noor, N, Alonso, T, Akturk, H, DeSalvo, D, Kamboj, M, Jacobsen, L, Scott, M, Ebekozien, O, Clements, M
Introduction: The use of continuous glucose monitors (CGM) and insulin pumps (PUMP) have been associated with improved outcomes in type 1 diabetes (T1D) care. Therefore, disengaging from these devices represents a risk for worsening health outcomes.
Objectives: We sought to evaluate the effect of the COVID-19 pandemic on device disengagement rates by race and ethnicity.
Methods: This retrospective cohort study Pre-COVID-19 [n = 15,838] + peri-COVID-19 ([n = 14,799]) used EMR data from 15 sites (i.e., 3 adult and 12 pediatric diabetes centers) within the T1D Exchange Quality Improvement Collaborative. We identified individuals using at least one Advanced Diabetes Technology (ADT [PUMP or CGM]) at their most recent visit. Individuals who continued to use that technology for at least two subsequent visits were classified as engaged. Those who reported not using ADT in two subsequent visits were classified as disengaged.